Abecarnil
阿贝卡尔
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameAbecarnil
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/SBayer AG
Active IndicationsN/A
Inactive Indications